Healthcare Services

Prenatal And Newborn Genetic Testing Market Revenue Growth Expected to Reach $13.65 Billion by 2030 with 12.6% CAGR

April 6, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Prenatal And Newborn Genetic Testing Market By 2030 Starting From Its 2026 Size?

The prenatal and newborn genetic testing market has experienced rapid expansion in its size over recent years. This market is projected to expand from $7.6 billion in 2025 to $8.51 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 12.0%. This historic growth can be linked to factors such as enhanced public understanding of genetic disorders, the broadening scope of maternal and neonatal healthcare, the proliferation of institutional screening initiatives, the wider accessibility of diagnostic laboratories, and advancements in the precision of genetic testing.

The prenatal and newborn genetic testing market is forecast to undergo significant expansion in the upcoming years. Its value is set to climb to $13.65 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.6%. This growth throughout the forecast period stems from factors such as the increasing acceptance of personalized medicine approaches, a heightened demand for identifying diseases in their early stages, the broadening scope of newborn screening mandates, increased financial commitments to genomics infrastructure, and the wider utilization of digital health platforms. Prominent trends expected in this period include the growing adoption of non-invasive prenatal testing, an increase in the deployment of advanced genetic screening panels, the greater integration of AI in assessing genetic risks, the expansion of high-throughput sequencing platforms, and a reinforced emphasis on the early detection of congenital disorders.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp

What Primary Drivers Are Shaping The Development Of The Prenatal And Newborn Genetic Testing Market?

The growing occurrence of genetic conditions is anticipated to boost the prenatal and newborn genetic testing market in the future. Genetic disorders are medical conditions that arise from abnormalities or mutations in an individual’s DNA or genetic material. Prenatal and newborn genetic testing enables the identification of genetic disorders at an early stage, often before symptoms become apparent, allowing healthcare providers to implement timely interventions and treatment strategies. For example, in May 2024, data from the Centers for Disease Control and Prevention (CDC), a US-based public health agency, indicated that sickle cell disease (SCD) affects about 100,000 people in the United States. Of those impacted, more than 90% are non-Hispanic Black or African American, while an estimated 3%-9% are Hispanic or Latino. Thus, the rising incidence of genetic disorders is a key driver for the prenatal and newborn genetic testing market.

Which Segment Categories Define The Prenatal And Newborn Genetic Testing Market?

The prenatal and newborn genetic testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments

2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings

3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia

4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers

Subsegments:

1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits

2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers

What Key Trends Are Influencing The Development Of The Prenatal And Newborn Genetic Testing Market?

Key companies operating in the prenatal and newborn genetic testing markets are focusing on developing innovative screening solutions, such as noninvasive prenatal screening tests, to improve accessibility and affordability while delivering reliable services to patients. Noninvasive prenatal screening (NIPS), also known as noninvasive prenatal testing (NIPT), is an advanced and safe genetic screening method performed during pregnancy to assess the risk of certain fetal chromosomal abnormalities. For example, in January 2024, Natera, Inc., a US-based genetic testing company, launched a fetal RhD NIPT designed to determine fetal RhD status, helping obstetricians manage patient care during nationwide shortages of Rho(D) immune globulin (RhIg). The test is supported by a large clinical validation study involving over 650 RhD-negative patients with confirmed outcomes, demonstrating 100% sensitivity and more than 99% specificity. Natera’s test can be used early in pregnancy, enabling timely clinical decision-making and improving overall patient management.

Who Are The Top Companies Competing In The Prenatal And Newborn Genetic Testing Market?

Major companies operating in the prenatal and newborn genetic testing market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostic Incorporated, Agilent Technologies Inc, Illumina Inc, PerkinElmer Genomics, Quidel Corporation, Bio Rad Laboratories Inc, Qiagen NV, Werfen SA, DiaSorin SpA, BGI Group, Natera Inc, Trinity Biotech plc, Meridian Bioscience Inc, Sekisui Diagnostics, Ariosa Diagnostics Inc, AccuBioTech Co Ltd, Sequenom Inc, Roche Diagnostics International AG

Read the full prenatal and newborn genetic testing market report here:

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

How Does The Prenatal And Newborn Genetic Testing Market Perform Across Major Global Regions?

North America was the largest region in the prenatal and newborn genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Prenatal And Newborn Genetic Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp

Browse Through More Reports Similar to the Global Prenatal And Newborn Genetic Testing Market 2026, By The Business Research Company

Infertility Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report

Precocious Puberty Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/precocious-puberty-treatment-global-market-report

Fertility Treatments Global Market Report

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795